P0DTC9 (NCAP_SARS2) Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
Nucleoprotein UniProtKBInterProInteractive Modelling
419 aa; Sequence (Fasta) ;
4 identical sequences: Severe acute respiratory syndrome coronavirus 2: A0A6C0T6Z7, A0A6B9VLF5, A0A6V7AN48, A0A6V7AMQ7
It is possible new templates exist for this target since these models were created.
Available Structures
35 Experimental Structures
| Description | Oligo-state | Ligands | Structure | Range | ||
|---|---|---|---|---|---|---|
| Crystal Structure of Human Fab S24-202 in the complex with the N-terminal Domain of Nucleocapsid pr… |
Heteromer | 9×EDO; 12×IOD; 1×PO4; | ||||
| Assess | ||||||
| Structure of the SARS-CoV-2 N protein RNA-binding domain bound to single-domain antibody C2 |
Heteromer | 1×SO4; | ||||
| Assess | ||||||
| Structure of the SARS-CoV-2 N protein RNA-binding domain bound to single-domain antibody B6 |
Heteromer | |||||
| Assess | ||||||
| Complex structure of a human monoclonal antibody with SARS-CoV-2 nucleocapsid protein NTD |
Heteromer | 1×ZN; | ||||
| Assess | ||||||
| Crystal Structure of Human Fab S24-1564 in the complex with the N-terminal Domain of Nucleocapsid p… |
Heteromer | 7×EDO; 6×CL; | ||||
| Assess | ||||||
| Structure of the SARS-CoV-2 N protein C-terminal domain bound to single-domain antibody E2 |
Heteromer | |||||
| Assess | ||||||
| Crystal Structure of HLA-A*0201in complex with SARS-CoV-2 N222-230 |
Heteromer P61769; Q861F7; | 2×CD; 2×CA; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of HLA-A*0201 in complex with SARS-CoV-2 N316-324 |
Heteromer P61769; Q861F7; | 1×ACT; 2×CD; 4×NA; | ||||
| Assess | ||||||
| Crystal Structure of HLA-A*0201in complex with SARS-CoV-2 N159-167 |
Heteromer P61769; Q861F7; | |||||
| Assess | ||||||
| Crystal Structure of HLA-A*0201 in complex with SARS-CoV-2 N138-146 |
Heteromer P61769; Q861F7; | 2×CD; 1×ACT; | ||||
| Assess | ||||||
| Crystal Structure of HLA-A*0201in complex with SARS-CoV-2 N351-359 |
Heteromer P61769; Q861F7; | 3×3NI; 3×CL; 1×CD; | ||||
| Assess | ||||||
| HLA-B*07:02 in complex with SARS-CoV-2 nucleocapsid peptide N105-113 |
Heteromer P01889; P61769; | 3×CL; | ||||
| Assess | ||||||
| Crystal Structure of HLA-A*0201 in complex with SARS-CoV-2 N226-234 |
Heteromer P61769; Q861F7; | 2×CD; 1×NA; 1×ACT; | ||||
| Assess | ||||||
| GQTVTK segment from the Nucleoprotein of SARS-CoV-2, residues 243-248 | homo-18-mer | |||||
| Assess | ||||||
| AALALL segment from the Nucleoprotein of SARS-CoV-2, residues 217-222, crystal form 2 | homo-18-mer | 36×PG4; | ||||
| Assess | ||||||
| GSQASS segment from the Nucleoprotein of SARS-CoV-2, residues 179-184 | homo-16-mer | |||||
| Assess | ||||||
| AALALL SEGMENT FROM THE NUCLEOPROTEIN OF SARS-COV-2, RESIDUES 217-222, CRYSTAL FORM 1 | homo-12-mer | 18×TFA; | ||||
| Assess | ||||||
| Crystal structure of RNA-binding domain of nucleocapsid phosphoprotein from SARS CoV-2, monoclinic … | homo-4-mer | 4×ZN; 2×MES; | ||||
| Assess | ||||||
| Crystal structure of RNA binding domain of nucleocapsid phosphoprotein from SARS coronavirus 2 | homo-4-mer | 4×MES; 4×CL; 4×ZN; 4×GOL; | ||||
| Assess | ||||||
| Crystal Structure of C-terminal Dimerization Domain of Nucleocapsid Phosphoprotein from SARS-CoV-2,… | homo-2-mer | |||||
| Assess | ||||||
| 1.45 Angstrom Resolution Crystal Structure of C-terminal Dimerization Domain of Nucleocapsid Phosph… | homo-2-mer | |||||
| Assess | ||||||
| Crystal structure of SARS-CoV-2 nucleocapsid protein C-terminal RNA binding domain | homo-2-mer | 3×PEG; | ||||
| Assess | ||||||
| Structure of SARS-CoV-2 Nucleocapsid dimerization domain, P21 form | homo-2-mer | 3×SO4; | ||||
| Assess | ||||||
| Crystal structure of the C-terminal domain of SARS-CoV-2 nucleocapsid protein | homo-2-mer | 1×ACT; 1×PEG; | ||||
| Assess | ||||||
| Structure of SARS-CoV-2 Nucleocapsid dimerization domain, P1 form | homo-2-mer | |||||
| Assess | ||||||
| Crystal structure of 2019-nCoV nucleocapsid C-terminal domain (CTD) protein | homo-2-mer | |||||
| Assess | ||||||
| 2.05 Angstrom Resolution Crystal Structure of C-terminal Dimerization Domain of Nucleocapsid Phosph… | homo-2-mer | 2×CL; | ||||
| Assess | ||||||
| Crystal structure of SARS-CoV-2 nucleocapsid protein C-terminal RNA binding domain at 2.0A resoluti… | homo-2-mer | 6×PO4; 1×CL; | ||||
| Assess | ||||||
| SARS-CoV-2 nucleocapsid protein C-terminal domain (dodecamer) | homo-2-mer | |||||
| Assess | ||||||
| The N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein | monomer | |||||
| Assess | ||||||
| The SARS-CoV-2 nucleocapsid phosphoprotein N-terminal domain in complex with 7mer dsRNA | monomer | |||||
| Assess | ||||||
| The SARS-CoV-2 nucleocapsid phosphoprotein N-terminal domain in complex with 10mer ssRNA | monomer | |||||
| Assess | ||||||
| Crystal structure of 2019-nCoV nucleocapsid N-terminal domain (NTD) protein | monomer | |||||
| Assess | ||||||
| Crystal structure of the N-terminal domain of SARS-CoV-2 nucleocapsid protein | monomer | |||||
| Assess | ||||||
| Crystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domain | monomer | |||||
| Assess | ||||||
3 SWISS-MODEL models
| Oligo-state | Ligands | QMEANDisCo | Template | Range | Seq id (%) | |
|---|---|---|---|---|---|---|
| monomer | 0.75 | 2ofz.1.A | 92.06 | |||
| Assess | ||||||
| monomer | 0.69 | 4ud1.1.A | 55.41 | |||
| Assess | ||||||
| monomer | 0.59 | 6wzq.2.B | 100.00 | |||
| Assess | ||||||